HALOZYME REPORTS FOURTH QUARTER 2021 AND FULL YEAR RESULTS

Go back to HALOZYME REPORTS FOURTH QUARTER 2021 AND FULL YEAR RESULTS
Halozyme Therapeutics, Inc. (NASDAQ: HALO) Delayed: 104.43 +1.43 (1.39%)
Previous Close $103.00    52 Week High $18.39 
Open $102.95    52 Week Low $6.96 
Day High $104.51    P/E N/A 
Day Low $102.39    EPS $-0.58 
Volume 775,622